Ryosuke Fujiwara
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Metabolic and plasmid engineering to produce D-phenyllactic acid from glucose-xylose co-substrates in Escherichia coli.
Journal: Applied and environmental microbiology
Published: December 03, 2025
Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells.
Journal: Current issues in molecular biology
Published: August 16, 2025
Parallel metabolic pathway engineering for aerobic 1,2-propanediol production in Escherichia coli.
Journal: Biotechnology journal
Published: April 03, 2024
Styrene Production in Genetically Engineered Escherichia coli in a Two-Phase Culture.
Journal: Biotech (Basel (Switzerland))
Published: November 13, 2023
Relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia responding to retreatment with inotuzumab ozogamicin
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 06, 2023
Predictive value of early-phase heart rate reduction for subsequent recovery of left ventricular systolic function in heart failure with reduced ejection fraction.
Journal: Cardiology journal
Published: August 18, 2023
The E/e' ratio on echocardiography as an independent predictor of the improvement of left ventricular contraction in patients with heart failure with reduced ejection fraction.
Journal: Journal of clinical ultrasound : JCU
Published: May 07, 2023
Renoprotective effect of chronic treatment with sodium-glucose cotransporter 2 inhibitors and its associated factors in Japanese patients with chronic heart failure and diabetes.
Journal: International journal of cardiology. Heart & vasculature
Published: September 20, 2022
Caffeic acid production from glucose using metabolically engineered Escherichia coli.
Journal: Enzyme and microbial technology
Published: September 15, 2022
Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Journal: Biochemical and biophysical research communications
Published: July 17, 2022
G6P-capturing molecules in the periplasm of Escherichia coli accelerate the shikimate pathway.
Journal: Metabolic engineering
Published: September 08, 2021
Last Updated: 09/26/2026